RSV Vaccine (Clover Biopharmaceuticals)

呼吸道合胞病毒疫苗（三叶草）

Report date: 2025/03/26 15:58:08

Base Information

Drug NameRSV Vaccine (Clover Biopharmaceuticals)
Drug Alias NameRSV PreF-三聚体亚单位候选疫苗Bivalent Recombinant Respiratory Syncytial Virus (RSV) Vaccine (CHO Cell)(Clover Biopharmaceuticals)SCB-1019SCB-1019T
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesClover Biopharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesClover Biopharmaceuticals Aus Pty LtdClover PharmaceuticalsClover Biopharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A